TITLE

Co-infusion of adipose tissue derived mesenchymal stem cell-differentiated insulin-making cells and haematopoietic cells with renal transplantation: a novel therapy for type 1 diabetes mellitus with end-stage renal disease

AUTHOR(S)
Dave, Shruti D.; Vanikar, Aruna V.; Trivedi, Hargovind L.
PUB. DATE
May 2013
SOURCE
BMJ Case Reports;May2013, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
88013237

 

Related Articles

  • Mesenchymal stem cells derived from adipose tissue are not affected by renal disease. Roemeling-van Rhijn, Marieke; Reinders, Marlies E J; de Klein, Annelies; Douben, Hannie; Korevaar, Sander S; Mensah, Fane K F; Dor, Frank J M F; IJzermans, Jan N M; Betjes, Michiel G H; Baan, Carla C; Weimar, Willem; Hoogduijn, Martin J // Kidney International;Oct2012, Vol. 82 Issue 7, p748 

    Mesenchymal stem cells are a potential therapeutic agent in renal disease and kidney transplantation. Autologous cell use in kidney transplantation is preferred to avoid anti-HLA reactivity; however, the influence of renal disease on mesenchymal stem cells is unknown. To investigate the...

  • Effects of adipose-derived mesenchymal cells on ischemia-reperfusion injury in kidney. Furuichi, Kengo; Shintani, Hidemi; Sakai, Yoshio; Ochiya, Takahiro; Matsushima, Kouji; Kaneko, Shuichi; Wada, Takashi // Clinical & Experimental Nephrology;Oct2012, Vol. 16 Issue 5, p679 

    Background: Acute kidney injury (AKI) is a critical condition for kidney and other remote organs, including the lung. However, available treatments for AKI are limited. In this study, we explored the effect of adipose-derived mesenchymal cells on a mouse model of AKI. Methods: Adipose-derived...

  • Mesenchymal Stem Cell Therapy in Diabetes Mellitus: Progress and Challenges. El-Badri, Nagwa; Ghoneim, Mohamed A. // Journal of Nucleic Acids;2013, p1 

    Advanced type 2 diabetes mellitus is associated with significant morbidity and mortality due to cardiovascular, nervous, and renal complications. Attempts to cure diabetes mellitus using islet transplantation have been successful in providing a source for insulin secreting cells. However,...

  • Stem cell therapy for the treatment of parasitic infections: is it far away? Zhang, Yan; Mi, Jing-Yi; Rui, Yong-Jun; Xu, Yong-Liang; Wang, Wei // Parasitology Research;Feb2014, Vol. 113 Issue 2, p607 

    Stem cell therapy is an interventional treatment that introduces new cells into damaged tissues, which help in treating many diseases and injuries. It has been proved that stem cell therapy is effective for the treatment of cancers, diabetes mellitus, Parkinson's disease, Huntington's disease,...

  • Effects of bone marrow-derived stem cells on necrotic and apoptotic cell death induced by renal ischemia-reperfusion in rats. Yang Wang; Zhi Jian Wang; Gong Xian Wang; An Xie // Cell Research;Aug2008 Supplement, Vol. 18, pS80 

    Ischemia-reperfusion injury (IRI) is a crucial element in the pathogenesis of acute ischemic renal failure and can importantly influence the early functional recovery and even long-term survival of a transplanted kidney. It is generally thought that renal repair following IRI requires the...

  • Insights and Hopes in Umbilical Cord Blood Stem Cell Transplantations. Shahrokhi, Somayeh; Menaa, Farid; Alimoghaddam, Kamran; McGuckin, Colin; Ebtekar, Massoumeh // Journal of Biomedicine & Biotechnology;2012, Vol. 2012, p1 

    Over 20.000 umblical cord blood transplantations (UCBT) have been carried out around the world. Indeed, UCBT represents an attractive source of donor hematopoietic stem cells (HSCs) and, offer interesting features (e.g., lower graft-versus-host disease) compared to bone marrow transplantation...

  • Toward Personalized Cell Therapies by Using Stem Cells 2012. Isobe, Ken-ichi; Cheung, Herman S.; Ji Wu // Journal of Biomedicine & Biotechnology;2012, Vol. 2012, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including experiments using mesenchymal stem cells (MSCs), end-stage renal disease (ESRD), and future personalized therapy using MSC.

  • Toward Personalized Cell Therapies by Using Stem Cells 2012. Isobe, Ken-ichi; Cheung, Herman S.; Ji Wu // Journal of Biomedicine & Biotechnology;2012, Vol. 2012, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including experiments using mesenchymal stem cells (MSCs), end-stage renal disease (ESRD), and future personalized therapy using MSC.

  • Toward Personalized Cell Therapies by Using Stem Cells 2012. Isobe, Ken-ichi; Cheung, Herman S.; Ji Wu // Journal of Biomedicine & Biotechnology;2012, Vol. 2012, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including experiments using mesenchymal stem cells (MSCs), end-stage renal disease (ESRD), and future personalized therapy using MSC.

  • Toward Personalized Cell Therapies by Using Stem Cells 2012. Isobe, Ken-ichi; Cheung, Herman S.; Ji Wu // Journal of Biomedicine & Biotechnology;2012, Vol. 2012, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including experiments using mesenchymal stem cells (MSCs), end-stage renal disease (ESRD), and future personalized therapy using MSC.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics